Lukas Biomedical Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 77.897 million compared to TWD 89.871 million a year ago. Operating loss was TWD 21.535 million compared to TWD 392,000 a year ago. Net loss was TWD 24.219 million compared to TWD 2.714 million a year ago. Basic loss per share from continuing operations was TWD 0.74 compared to TWD 0.08 a year ago.